Acute Lymphoblastic Leukemia (ALL)
Diagnosing Acute Lymphoblastic Leukemia
Presently, there are no special screening tests that can detect ALL at a very early stage.
In our Hemato-Oncology Division, we use a variety of specialized tests to obtain a precise, prompt, and reliable Diagnosing Acute Lymphoblastic Leukemia in Israel
and the exact subtype of the cancer. Since this disease is relatively rare in adults, it is critical to undergo testing by an experienced team of medical experts, like the highly qualified physicians at Sheba Medical Center.
Blood tests are generally the first step in diagnosing leukemia. These include taking a CBC (complete blood count) and a blood smear. Changes in the amount and appearance of different blood cells can help diagnose leukemia. Typically, patients with ALL have an abundance of lymphoblasts (immature white cells), and an insufficient amount of red blood cells or platelets.
Bone Marrow Biopsy
If the blood test results are suspicious, a bone marrow biopsy and aspiration is then done to assess the bone marrow. This test can diagnose ALL with a high level of accuracy. Cytogenetic and molecular analyses are performed from the aspiration.
Additional laboratory tests are performed to determine the specific subtype of ALL.
Spinal Tap or Lumbar Puncture
A spinal tap or lumbar puncture is performed to determine whether or not the leukemia has spread to the central nervous system.
MRI or CT Scan
An MRI scan may be performed to assess whether ALL has spread to the area surrounding the brain.